Ngjk UAS system to be introduced at K-P varsities
ISLAMABAD:The government will hold road shows in China, Germany and other major economies in coming months in an effort to stimulate foreign direct investment (FDI) flow into the country, the Board of Investment (BOI) announced on Friday.Under the new work plan, BOI will organise road shows in collaboration with different chambers of c campus adidas femme ommerce and All Pakistan Textile Mills Association (Aptma) for focusing on textile and steel industries, said BOI spokesman Shah Jahan while talking to APP."We are mainly focused on achieving the FDI target of $15 billion by 2025," he said.He expected huge foreign investment in the automobile sector from different groups because of prudent policies, bel zapatillas nb ieving foreign investors were keen to invest in Pakistan. "The government is committed to offering ease of doing business to foreign investors and also global competitiveness to multinational companies," Shah Jahan added.Published in The Express Tribune adidas campus bianche , April 22nd, 2017.Like聽Business on Facebook, follow @T Domantis Limited has announced a multi-target discovery collaboration with聽Bristol-Myers Squibb Company to develop dAb therapeutics for uses in the fields of immunology and oncology.The collaborators aim to discover a range of dAbs to add nike airforce ress therapeutic targets involved new balance 574 in T-cell co-stimulation (pa nike dunk rt of the human immune response), some of which may not be amenable to targeting with conventional antibody approaches.Under the terms of the agreement, Domantis will receive $9.2 million in upfront and guaranteed research payments. In addition, Domantis will be eligible for pre-clinical and clinical milestone payments of up to $20 million per product, as well as royalties on product sales. Domantis will contribute two of its existing dAb therapeutic programs and will create a range of dAbs to predetermined targets, with Bristol-Myers Squibb having the exclusive right to develop and commercialize dAb therapeutics discovered during the collaboration."This is an exciting time for Domantis. We